These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11107740)

  • 1. [Venous thromboembolism, warfarin and cancer--a well-known connection].
    Schulman S
    Lakartidningen; 2000 Oct; 97(41):4554. PubMed ID: 11107740
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Seneviratne C; Kupfer Y; Tessler S
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879892
    [No Abstract]   [Full Text] [Related]  

  • 3. Warfarin for venous thromboembolism - walking the dosing tightrope.
    Schafer AI
    N Engl J Med; 2003 Apr; 348(15):1478-80. PubMed ID: 12601074
    [No Abstract]   [Full Text] [Related]  

  • 4. Duration of anticoagulation after first episode of unprovoked venous thromboembolism.
    Abdel-Razeq HN; Radwi GR
    Saudi Med J; 2004 Nov; 25(11):1776; author reply 1776-7. PubMed ID: 15573235
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence-based initiation of warfarin (Coumadin).
    Ebell MH
    Am Fam Physician; 2005 Feb; 71(4):763-5. PubMed ID: 15742915
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence-based adjustment of warfarin (Coumadin) doses.
    Ebell MH
    Am Fam Physician; 2005 May; 71(10):1979-82. PubMed ID: 15926414
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    van Dongen CJ; Prins MH; Büller HR
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12878749
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Aberegg SK
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879891
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Cosmi B; Palareti G
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879889
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Krishnan JA; Streiff MB
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879888
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Tran HA
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658126
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS
    Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiating warfarin therapy: 5 mg versus 10 mg.
    Eckhoff CD; Didomenico RJ; Shapiro NL
    Ann Pharmacother; 2004 Dec; 38(12):2115-21. PubMed ID: 15522981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis].
    Schulman S
    Lakartidningen; 2003 Jun; 100(24):2118-21. PubMed ID: 12841107
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term prophylaxis after venous thromboembolism].
    Gøtze JP; Friis-Hansen LJ; Thorsen S; Rehfeld JF
    Ugeskr Laeger; 2003 Jul; 165(29):2896-7. PubMed ID: 12908362
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Brotman DJ
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658124
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Huisman MV; van der Meer FJ; van Rooden CJ; Prins MH
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14645647
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Malik V; Kupfer Y; Tessler S
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658127
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombosis prophylaxis in cancer patients with a central venous catheter.
    Laporte S; Decousus H; Mismetti P
    Arch Intern Med; 2004 Feb; 164(4):459; author reply 459-60. PubMed ID: 14980999
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Glynn RJ
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.